Brief: Delcath Systems Announces Investigator-Initiated Chopin Phase 2 Trial Presentation At ESMO 2025 Congress
22/09/2025 21:54
Sept 22 (Reuters) - Delcath Systems Inc DCTH.O: DELCATH SYSTEMS ANNOUNCES INVESTIGATOR-INITIATED CHOPIN PHASE 2 TRIAL PRESENTATION AT ESMO 2025 CONGRESS Source text: ID:nBw1qXhCsa Further company coverage: DCTH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Delcath Systems
See all newsBrief: Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Delcath Systems Q1 revenue beats on Hepzato growth
Brief: Delcath Systems Announces Publication Of Chopin Clinical Trial Results In The Lancet Oncology
Delcath Q4 revenue rises 37%, beats estimates
Brief: Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)